The transfection reagents and equipment market size has grown rapidly in recent years. It will grow from $1.74 billion in 2025 to $1.93 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to expansion of molecular biology research activities, increasing use of cell-based assays, growth of recombinant protein production, rising academic and industrial genomics research, availability of advanced transfection chemistries.
The transfection reagents and equipment market size is expected to see rapid growth in the next few years. It will grow to $2.97 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to increasing adoption of CRISPR and gene therapy research, rising demand for scalable transfection platforms, expansion of biopharmaceutical pipeline development, growing investment in precision medicine, increasing automation in life science laboratories. Major trends in the forecast period include increasing adoption of high-efficiency transfection reagents, rising demand for gene editing-compatible delivery systems, growing use of non-viral transfection methods, expansion of automated transfection instruments, enhanced focus on cell-type specific transfection solutions.
The increasing number of cancer patients worldwide is expected to drive growth in the transfection reagents and equipment market in the coming years. Cancer comprises a group of diseases characterized by abnormal and uncontrolled cell growth. Transfection reagents are widely used in cancer research to introduce foreign genetic material, such as plasmid DNA or RNA molecules, allowing researchers to study gene expression, gene silencing, drug screening, and target validation. For example, in July 2024, Cancer Research UK, a UK-based cancer charity, projected that cancer incidence rates in the United Kingdom will rise for most types between 2023-2025 and 2038-2040, with increases ranging from less than 1% for breast cancer to 50% for eye cancer, while a smaller number of cancers are expected to decline, with reductions ranging from 2% for lung cancer to 27% for mesothelioma. Thus, the growing number of cancer patients worldwide is fueling growth in the transfection reagents and equipment market.
Key companies in the transfection reagents and equipment market are focusing on innovations such as GMP-grade AAV transfection reagents to enhance viral vector production efficiency and support large-scale gene therapy manufacturing. A GMP-grade AAV transfection reagent is a regulatory-compliant formulation designed to deliver genetic material efficiently into suspension cell cultures for scalable production of recombinant adeno-associated virus vectors. For example, in July 2025, Yeasen Biotechnology, a China-based biotechnology manufacturer, received U.S. FDA Drug Master File acceptance for its UltraAAV PEI Transfection Reagent - GMP grade. The reagent demonstrates substantially higher viral titers and improved full capsid ratios across multiple adeno-associated virus serotypes, offering superior performance compared with standard formulations. It also enhances manufacturing efficiency by achieving comparable vector yields with reduced reagent usage while meeting strict regulatory and quality standards suitable for clinical and commercial gene therapy production.
In March 2023, Sartorius AG, a Germany-based analytical laboratory instrument manufacturing company, acquired Polyplus-Transfection SA for $2.6 billion. This acquisition positions Sartorius AG strongly in the rapidly expanding cell and gene therapy markets, supporting business growth and meeting the escalating demand for cell and gene therapies. Polyplus-Transfection SA, a France-based biotechnology company, specializes in the development of transfection reagents and equipment.
Major companies operating in the transfection reagents and equipment market are Thermo Fisher Scientific Inc., Promega Corporation, Qiagen N.V., Bio-Rad Laboratories Inc., MaxCyte Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, OriGene Technologies Inc., Altogen Biosystems, Applied Biological Materials Inc., Bex Co. Ltd., Takara Bio Inc., Polyplus-transfection SA, Sigma-Aldrich Corporation, Transfection Technologies Inc., Viromer, ABM Inc., chemicell GmbH, Genlantis, Biontech Laboratories GmbH, Jena Bioscience GmbH, PromoCell GmbH, PerkinElmer Inc., Sartorius AG, Hoffmann-La Roche Ltd., Bio-Techne Corporation, Biotium Inc., Cell Applications Inc.
North America was the largest region in the transfection reagents and equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection reagents and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the transfection reagents and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the transfection reagents and equipment market by increasing costs of imported biochemical reagents, specialized polymers, lipid formulations, electroporation systems, and precision laboratory instruments. Research institutions and biopharmaceutical companies in North America and Europe are most affected due to reliance on imported high-grade reagents and equipment, while Asia-Pacific faces higher manufacturing input costs. These tariffs are increasing operational expenses and procurement timelines for laboratories. However, they are also encouraging domestic reagent production, regional manufacturing expansion, and local sourcing strategies that strengthen long-term supply chain stability.
The transfection reagents and equipment market research report is one of a series of new reports that provides transfection reagents and equipment market statistics, including transfection reagents and equipment industry global market size, regional shares, competitors with a transfection reagents and equipment market share, detailed transfection reagents and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the transfection reagents and equipment industry. This transfection reagents and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Transfection reagents are substances or kits employed for introducing foreign genetic material, such as DNA or RNA, into cells. These reagents play a crucial role in facilitating the delivery of nucleic acids into cells, enabling researchers to explore gene expression, manipulate gene function, or produce recombinant proteins.
Within the realm of transfection reagents and equipment, the primary categories encompass instruments and reagents, along with kits. Transfection instruments are specialized laboratory tools designed to streamline the delivery of foreign nucleic acids, such as DNA or RNA, into cells during the transfection process. The range of molecules involved includes plasmid DNA, DNA oligonucleotides, small interfering RNA (siRNA), proteins, ribonucleoprotein complexes (RNPs), and others. Various organisms, including bacteria, mammalian cells, fungi, plants, and viruses, serve as recipients for these molecules. These products find application across diverse end-users, including biopharma, contract research organizations (CROs), contract manufacturing organizations (CMOs), contract development and manufacturing organizations (CDMOs), academia, hospitals, clinical labs, and others.
The transfection reagents and equipment market consists of sales of lipid-based transfection reagents, cationic polymer-based transfection reagents, calcium phosphate-based transfection reagents, viral transduction tools, transfection control plasmids, transfection validation tools, and electroporation systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The transfection reagents and equipment market size is expected to see rapid growth in the next few years. It will grow to $2.97 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to increasing adoption of CRISPR and gene therapy research, rising demand for scalable transfection platforms, expansion of biopharmaceutical pipeline development, growing investment in precision medicine, increasing automation in life science laboratories. Major trends in the forecast period include increasing adoption of high-efficiency transfection reagents, rising demand for gene editing-compatible delivery systems, growing use of non-viral transfection methods, expansion of automated transfection instruments, enhanced focus on cell-type specific transfection solutions.
The increasing number of cancer patients worldwide is expected to drive growth in the transfection reagents and equipment market in the coming years. Cancer comprises a group of diseases characterized by abnormal and uncontrolled cell growth. Transfection reagents are widely used in cancer research to introduce foreign genetic material, such as plasmid DNA or RNA molecules, allowing researchers to study gene expression, gene silencing, drug screening, and target validation. For example, in July 2024, Cancer Research UK, a UK-based cancer charity, projected that cancer incidence rates in the United Kingdom will rise for most types between 2023-2025 and 2038-2040, with increases ranging from less than 1% for breast cancer to 50% for eye cancer, while a smaller number of cancers are expected to decline, with reductions ranging from 2% for lung cancer to 27% for mesothelioma. Thus, the growing number of cancer patients worldwide is fueling growth in the transfection reagents and equipment market.
Key companies in the transfection reagents and equipment market are focusing on innovations such as GMP-grade AAV transfection reagents to enhance viral vector production efficiency and support large-scale gene therapy manufacturing. A GMP-grade AAV transfection reagent is a regulatory-compliant formulation designed to deliver genetic material efficiently into suspension cell cultures for scalable production of recombinant adeno-associated virus vectors. For example, in July 2025, Yeasen Biotechnology, a China-based biotechnology manufacturer, received U.S. FDA Drug Master File acceptance for its UltraAAV PEI Transfection Reagent - GMP grade. The reagent demonstrates substantially higher viral titers and improved full capsid ratios across multiple adeno-associated virus serotypes, offering superior performance compared with standard formulations. It also enhances manufacturing efficiency by achieving comparable vector yields with reduced reagent usage while meeting strict regulatory and quality standards suitable for clinical and commercial gene therapy production.
In March 2023, Sartorius AG, a Germany-based analytical laboratory instrument manufacturing company, acquired Polyplus-Transfection SA for $2.6 billion. This acquisition positions Sartorius AG strongly in the rapidly expanding cell and gene therapy markets, supporting business growth and meeting the escalating demand for cell and gene therapies. Polyplus-Transfection SA, a France-based biotechnology company, specializes in the development of transfection reagents and equipment.
Major companies operating in the transfection reagents and equipment market are Thermo Fisher Scientific Inc., Promega Corporation, Qiagen N.V., Bio-Rad Laboratories Inc., MaxCyte Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, OriGene Technologies Inc., Altogen Biosystems, Applied Biological Materials Inc., Bex Co. Ltd., Takara Bio Inc., Polyplus-transfection SA, Sigma-Aldrich Corporation, Transfection Technologies Inc., Viromer, ABM Inc., chemicell GmbH, Genlantis, Biontech Laboratories GmbH, Jena Bioscience GmbH, PromoCell GmbH, PerkinElmer Inc., Sartorius AG, Hoffmann-La Roche Ltd., Bio-Techne Corporation, Biotium Inc., Cell Applications Inc.
North America was the largest region in the transfection reagents and equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection reagents and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the transfection reagents and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the transfection reagents and equipment market by increasing costs of imported biochemical reagents, specialized polymers, lipid formulations, electroporation systems, and precision laboratory instruments. Research institutions and biopharmaceutical companies in North America and Europe are most affected due to reliance on imported high-grade reagents and equipment, while Asia-Pacific faces higher manufacturing input costs. These tariffs are increasing operational expenses and procurement timelines for laboratories. However, they are also encouraging domestic reagent production, regional manufacturing expansion, and local sourcing strategies that strengthen long-term supply chain stability.
The transfection reagents and equipment market research report is one of a series of new reports that provides transfection reagents and equipment market statistics, including transfection reagents and equipment industry global market size, regional shares, competitors with a transfection reagents and equipment market share, detailed transfection reagents and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the transfection reagents and equipment industry. This transfection reagents and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Transfection reagents are substances or kits employed for introducing foreign genetic material, such as DNA or RNA, into cells. These reagents play a crucial role in facilitating the delivery of nucleic acids into cells, enabling researchers to explore gene expression, manipulate gene function, or produce recombinant proteins.
Within the realm of transfection reagents and equipment, the primary categories encompass instruments and reagents, along with kits. Transfection instruments are specialized laboratory tools designed to streamline the delivery of foreign nucleic acids, such as DNA or RNA, into cells during the transfection process. The range of molecules involved includes plasmid DNA, DNA oligonucleotides, small interfering RNA (siRNA), proteins, ribonucleoprotein complexes (RNPs), and others. Various organisms, including bacteria, mammalian cells, fungi, plants, and viruses, serve as recipients for these molecules. These products find application across diverse end-users, including biopharma, contract research organizations (CROs), contract manufacturing organizations (CMOs), contract development and manufacturing organizations (CDMOs), academia, hospitals, clinical labs, and others.
The transfection reagents and equipment market consists of sales of lipid-based transfection reagents, cationic polymer-based transfection reagents, calcium phosphate-based transfection reagents, viral transduction tools, transfection control plasmids, transfection validation tools, and electroporation systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Transfection Reagents and Equipment Market Characteristics
3. Transfection Reagents and Equipment Market Supply Chain Analysis
4. Global Transfection Reagents and Equipment Market Trends and Strategies
5. Transfection Reagents and Equipment Market Analysis of End Use Industries
7. Global Transfection Reagents and Equipment Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Transfection Reagents and Equipment Total Addressable Market (TAM) Analysis for the Market
9. Transfection Reagents and Equipment Market Segmentation
10. Transfection Reagents and Equipment Market Regional and Country Analysis
11. Asia-Pacific Transfection Reagents and Equipment Market
12. China Transfection Reagents and Equipment Market
13. India Transfection Reagents and Equipment Market
14. Japan Transfection Reagents and Equipment Market
15. Australia Transfection Reagents and Equipment Market
16. Indonesia Transfection Reagents and Equipment Market
17. South Korea Transfection Reagents and Equipment Market
18. Taiwan Transfection Reagents and Equipment Market
19. South East Asia Transfection Reagents and Equipment Market
20. Western Europe Transfection Reagents and Equipment Market
21. UK Transfection Reagents and Equipment Market
22. Germany Transfection Reagents and Equipment Market
23. France Transfection Reagents and Equipment Market
24. Italy Transfection Reagents and Equipment Market
25. Spain Transfection Reagents and Equipment Market
26. Eastern Europe Transfection Reagents and Equipment Market
27. Russia Transfection Reagents and Equipment Market
28. North America Transfection Reagents and Equipment Market
29. USA Transfection Reagents and Equipment Market
30. Canada Transfection Reagents and Equipment Market
31. South America Transfection Reagents and Equipment Market
32. Brazil Transfection Reagents and Equipment Market
33. Middle East Transfection Reagents and Equipment Market
34. Africa Transfection Reagents and Equipment Market
36. Transfection Reagents and Equipment Market Competitive Landscape and Company Profiles
37. Transfection Reagents and Equipment Market Other Major and Innovative Companies
40. Transfection Reagents and Equipment Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Transfection Reagents And Equipment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses transfection reagents and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for transfection reagents and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The transfection reagents and equipment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Instruments; Reagent And Kits2) By Types Of Molecule: Plasmid DNA; DNA Oligonucleotides; Small Interfering RNA (SiRNA); Proteins; Ribonucleoprotein Complexes (RNPs); Other Molecules
3) By End User: Biopharma; Contract Research Organizations (CROs); Academia
Subsegments:
1) By Instruments: Electroporation Systems; Microinjection Systems; Particle Bombardment Systems2) By Reagent And Kits: Lipid-Based Transfection Reagents; Polymer-Based Transfection Reagents; Protein-Based Transfection Reagents; Nucleic Acid Delivery Kits
Companies Mentioned: Thermo Fisher Scientific Inc.; Promega Corporation; Qiagen N.V.; Bio-Rad Laboratories Inc.; MaxCyte Inc.; Lonza Group Ltd.; Merck KGaA; Mirus Bio LLC; OriGene Technologies Inc.; Altogen Biosystems; Applied Biological Materials Inc.; Bex Co. Ltd.; Takara Bio Inc.; Polyplus-transfection SA; Sigma-Aldrich Corporation; Transfection Technologies Inc.; Viromer; ABM Inc.; chemicell GmbH; Genlantis; Biontech Laboratories GmbH; Jena Bioscience GmbH; PromoCell GmbH; PerkinElmer Inc.; Sartorius AG; Hoffmann-La Roche Ltd.; Bio-Techne Corporation; Biotium Inc.; Cell Applications Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Transfection Reagents and Equipment market report include:- Thermo Fisher Scientific Inc.
- Promega Corporation
- Qiagen N.V.
- Bio-Rad Laboratories Inc.
- MaxCyte Inc.
- Lonza Group Ltd.
- Merck KGaA
- Mirus Bio LLC
- OriGene Technologies Inc.
- Altogen Biosystems
- Applied Biological Materials Inc.
- Bex Co. Ltd.
- Takara Bio Inc.
- Polyplus-transfection SA
- Sigma-Aldrich Corporation
- Transfection Technologies Inc.
- Viromer
- ABM Inc.
- chemicell GmbH
- Genlantis
- Biontech Laboratories GmbH
- Jena Bioscience GmbH
- PromoCell GmbH
- PerkinElmer Inc.
- Sartorius AG
- Hoffmann-La Roche Ltd.
- Bio-Techne Corporation
- Biotium Inc.
- Cell Applications Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.93 Billion |
| Forecasted Market Value ( USD | $ 2.97 Billion |
| Compound Annual Growth Rate | 11.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 30 |
